The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Late morbidity and mortality among survivors of neuroblastoma treated with contemporary therapy: A report from the Childhood Cancer Survivor Study.
 
Danielle Novetsky Friedman
Consulting or Advisory Role - Fennec Pharma
 
Pamela J. Goodman
No Relationships to Disclose
 
Wendy M. Leisenring
No Relationships to Disclose
 
Lisa Diller
Stock and Other Ownership Interests - Amgen (I); Baxter (I); crispr therapeutics (I); LabCorp (I); Novartis (I); Portola Pharmaceuticals (I); Regenxbio (I); Roche (I); Spark Therapeutics (I)
 
Susan Lerner Cohn
Stock and Other Ownership Interests - Abbvie; Accelerated Medical Diagnostics; Amgen; Amgen (I); Gilead Sciences; Lilly; Merck; Novo Nordisk; Pfizer; Pfizer (I); Sanofi; Stryker; Stryker (I); Teva; United Health Group
Research Funding - Merck (Inst); United Therapeutics (Inst)
 
Emily S. Tonorezos
No Relationships to Disclose
 
Rebecca M. Howell
Research Funding - MD Anderson Cancer Center
 
Susan A. Smith
No Relationships to Disclose
 
Suzanne L. Wolden
No Relationships to Disclose
 
Joseph Philip Neglia
No Relationships to Disclose
 
Kirsten K. Ness
No Relationships to Disclose
 
Todd M. Gibson
No Relationships to Disclose
 
Paul C. Nathan
No Relationships to Disclose
 
Leslie L. Robison
No Relationships to Disclose
 
Kevin C. Oeffinger
No Relationships to Disclose
 
Gregory T. Armstrong
No Relationships to Disclose
 
Charles A. Sklar
Honoraria - Novo Nordisk
Patents, Royalties, Other Intellectual Property - UpToDate
Travel, Accommodations, Expenses - Novo Nordisk
 
Tara O. Henderson
Research Funding - Seagen
Other Relationship - Seagen
(OPTIONAL) Uncompensated Relationships - National Academies of Medicine, Engineering and Sciences Committee on Disability and Childhood Cancer